Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
Clinical trial NCT05387512 · COMPLETED
Trial details
- NCT number
- NCT05387512
- Sponsor
- Affiliated Hospital of Nantong University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-01
- Primary completion
- 2025-05-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.